Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.

Autor: Lee, K. C.1, Hamstra, D. A.2, Bullarayasamudram, S.2, Bhojani, M. S.2, Moffat, B. A.3,4, Dornfeld, K. J.2, Ross, B. D.1,3,4, Rehemtulla, A.2,3,4 alnawaz@umich.edu
Zdroj: Gene Therapy. Jan2006, Vol. 13 Issue 2, p127-137. 11p. 1 Diagram, 5 Graphs.
Databáze: Academic Search Ultimate